Precision Biosciences Inc

NASDAQ:DTIL   3:59:23 PM EDT
9.38
-0.12 (-1.26%)
Products, Other Pre-Announcement

Precision Biosciences And Servier Expand Car T Oncology Development Collaboration With Four New Programs

Published: 09/17/2020 11:27 GMT
Precision Biosciences Inc (DTIL) - Precision Biosciences and Servier Expand Car T Oncology Development Collaboration With Four New Programs Targeting Hematological and Solid Tumors.
Precision Biosciences - Servier Has Selected 2 Hematological & 2 Solid Tumor Targets Beyond Those Already in Precision's Allogeneic Car T Pipeline.
Precision Biosciences Inc - Precision Expects to Receive Milestone Payments in 2020 and 2021.